Mature tertiary lymphoid structure is a specific biomarker of cancer immunotherapy and does not predict outcome to chemotherapy in non-small-cell lung cancer
Ann Oncol. 2022 Oct;33(10):1084-1085.
doi: 10.1016/j.annonc.2022.06.007.
Epub 2022 Jun 25.
1 Department of Medicine, Institut Bergonié, Bordeaux, France; Faculty of Medicine, University of Bordeaux, Bordeaux, France.
2 Faculty of Medicine, University of Bordeaux, Bordeaux, France; Department of Radiology, CHU of Bordeaux, Bordeaux, France.
3 Department of Medicine, Institut Bergonié, Bordeaux, France.
4 Faculty of Medicine, University of Bordeaux, Bordeaux, France; Department of Pathology, Institut Bergonié, Bordeaux, France.
5 Explicyte, Bordeaux, France.
6 Department of Medicine, Institut Bergonié, Bordeaux, France; Faculty of Medicine, University of Bordeaux, Bordeaux, France; Gustave Roussy, DITEP, Villejuif, France. Electronic address: a.italiano@bordeaux.unicancer.fr.